EOLS
Evolus Inc.
Company Overview
| Mkt Cap | $455.39M | Price | $6.46 |
| Volume | 2.51M | Change | -3.87% |
| P/E Ratio | -9.0 | Open | $6.67 |
| Revenue | $266.3M | Prev Close | $6.72 |
| Net Income | $-50.4M | 52W Range | $5.71 - $17.44 |
| Div Yield | N/A | Target | $19.40 |
| Overall | 52 | Value | 40 |
| Quality | 71 | Technical | 45 |
No chart data available
Stock Overview
Updated DailyEvolus Inc. (EOLS) is a leading Healthcare company in the Drug Manufacturers - Specialty & Generic industry, currently trading at $6.46 with a market capitalization of $455.39 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows EOLS with a volume of 2.51 million shares. The stock opened down 0.74% from yesterday's close of $6.72. Current analyst estimates project earnings of $-0.77 per share for this year, with next year targeting $0.09.
EOLS demonstrates neutral technical outlook based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including OTIC, OTLC, OVAT-CA, ORTH-CA.
Key investment considerations for EOLS include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 200.3%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 03:56 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | EOLS | $6.46 | -3.9% | 2.51M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |